Alliance for Clinical Trials in Oncology

Utilizing the best science to develop promising new cancer therapies and prevention strategies for cancer.

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

Promising results for stage III lung cancer: The AFT 46/CHIO3 trial study show combining immunotherapy and chemotherapy before surgery improves outcomes for against with locally advanced non-small cell lung cancer. @LindaMThoracic @alliance_org #LCSM https://t.co/IEq6sOoATU

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

Dr. Ugonma Chukwueke of @DanaFarber leads a new Alliance trial exploring if adding a targeted medicine called vorasidenib to the usual treatment can help people with newly diagnosed IDH mutated grade 3 astrocytoma, a type of brain cancer. https://t.co/XRITzd4tBJ #clinicaltrials

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

Important news from #ASCO26: AFT-47 led by @CaPsurvivorship from @DanaFarber found hormone therapy darolutamide was associated with significantly less cognitive decline than enzalutamide for advanced prostate cancer. Read the full update @ALLIANCE_org https://t.co/6qtm9Z5dYM

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

@BradMcG04 of @DanaFarber leads @ALLIANCE_org A032201 (STRIKE) to see if adding the anti-cancer drug tivozanib to the standard treatment of immunotherapy after surgery helps patients with high-risk renal cell cancer. Learn more: https://t.co/BN81H5OBQ2 #NCI #PCSM #clinicaltrials

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

Twitter: Trial Tuesday! @DrRanaMcKayMD @UCSDHealth and @mishabeltran @DanaFarber_GU co-lead @ALLIANCE_org A032102/PREDICT evaluating if genetic testing helps determine the best treatment regimen for men with metastatic prostate cancer. Learn more: https://t.co/Pvsjc2y0Pd #PCsm

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

Now enrolling! @ThomasHopeMD of @UCSFHospitals and Deaglan McHugh of @MSKCancerCenter lead Alliance A032304 (RECIPROCAL), a phase III study to optimize targeted radiation therapy to minimize side effects while preserving efficacy in prostate cancer https://t.co/2UotzNquk5

[Dana-Farber News @DanaFarberNews]

New research by @DanaFarber’s Dr. Suzanne George in @JNCI_Now describes the user-centered development and pilot implementation of the Participant Engagement Portal (PEP) by @ALLIANCE_org to improve information flow and support participation-directed communication. Read more: https://t.co/NqcBCtCvEV

[The ASCO Post @ASCOPost]

💡 Better patient engagement could strengthen #cancerresearch. The Participant Engagement Portal from @ALLIANCE_org enabled communication, high satisfaction & patient data collection to support clinical trials.
����‍⚕️ Norah Crossnohere, PhD, MHS | @JNCI_Now
🔗 https://t.co/l9fisJwCvQ

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

New trial! The Alliance has a new clinical trial for adults who need first-line therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma. Visit https://t.co/dfdhVOzGq8 to learn about Alliance A042302 led by Dr. Jennifer R. Brown of @DanaFarber.

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

Alliance Announces FDA Acceptance of Supplemental Biologics License Application Supported by Results from the Phase III ATOMIC Trial for Patients with Stage III dMMR Colon Cancer - read more: https://t.co/OnNUaccFbD #NCI #NCTN #CancerResearch #ColonCancer @ALLIANCE_org

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

@HaeseongPark1 of @DanaFarber leads Alliance A022102 studying mFOLFIRINOX vs mFOLFOX with or without immunotherapy drug nivolumab for metastatic HER2 negative esophageal, gastroesophageal junction and gastric cancer. More: https://t.co/VJQWk9k5K8 #ColorectalCancer #clinicaltrials

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

Now enrolling! Angela Bradbury MD @PennCancer leads @ALLIANCE_org
A232301CD seeing if digital chatbot intervention is as effective as standard remote genetic services in increasing counseling uptake among #AYA #cancer patients https://t.co/4YGbUEUVFH #AYACancerAwareness

[Frank Sinicrope, MD @FASinicropeMD]

This trial aims to identify persons with Lynch syndrome and non-Lynch by improving rates of cascade germline testing in first-degree relatives of probands with new diagnosis of CRC. Led by myself and Heather Hampel. @FASinicropeMD

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

Publication alert! A new randomized trial led by Dr. Ellen Smith of @uabmedicine in @JCOOP_ASCO shows duloxetine, a common anti-depressant, does not prevent nerve damage caused by chemotherapy in patients with colorectal cancer. https://t.co/gxAmTGZNW7 https://t.co/U8TTYq8FcT

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

With colorectal cancer, if a person has an inherited gene change, other family members are at risk. Alliance A212101 will see if family members are more likely to get genetic testing to catch disease early if they hear from a healthcare provider. More at https://t.co/bDGAzWSz5c

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

@JNCI_Now article highlights the success of @Alliance_org secure PEP platform in a national pilot study.
📊 96%: Easy to access
📊 93%: Surveys easy to compete
📊 93%: Yes to future research
Read the story: https://t.co/2f8jvj8ur8
Read the article: https://t.co/VIXBCipJWT

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

@JNCI_Now article highlights the success of @Alliance_Onc's secure PEP platform in a national pilot study.
📊 96%: Easy to access
📊 93%: Surveys easy to compete
📊 93%: Yes to future research
Read the story: https://t.co/2f8jvj8ur8
Read the article: https://t.co/VIXBCipJWT

[The Cancer Letter @TheCancerLetter]

. @Labcorp and @Alliance_org partner to support multi-institution trial to expand genetic testing in CRC
https://t.co/yKTkvjsLeZ

[UCLA Jonsson Comprehensive Cancer Center @UCLAHealthJCCC]

As co-chair of the Cancer in the Older Adult Committee for The Alliance for Clinical Trials in Oncology (@ALLIANCE_org), @minasedrakmd will help guide the committee’s research efforts aimed at improving care for older adults with cancer.
https://t.co/UDj6wmKbTP

[Metro-MN Community Oncology Research Consortium @MMCORC]

New trial! MMCORC has a new #clinicaltrial testing the addition of Anti-Cancer Drug SONROTOCLAX, to the standard treatment ZANUBRUTINIB for chronic lymphocytic leukemia or small lymphocytic lymphoma. Visit https://t.co/sehjxRhSOl to learn about Alliance A042302.